160 related articles for article (PubMed ID: 18663360)
1. hPMC2 is required for recruiting an ERbeta coactivator complex to mediate transcriptional upregulation of NQO1 and protection against oxidative DNA damage by tamoxifen.
Sripathy SP; Chaplin LJ; Gaikwad NW; Rogan EG; Montano MM
Oncogene; 2008 Oct; 27(49):6376-84. PubMed ID: 18663360
[TBL] [Abstract][Full Text] [Related]
2. The exonuclease activity of hPMC2 is required for transcriptional regulation of the QR gene and repair of estrogen-induced abasic sites.
Krishnamurthy N; Ngam CR; Berdis AJ; Montano MM
Oncogene; 2011 Nov; 30(47):4731-9. PubMed ID: 21602889
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of the human quinone reductase gene by antiestrogen-liganded estrogen receptor-alpha and estrogen receptor-beta.
Montano MM; Jaiswal AK; Katzenellenbogen BS
J Biol Chem; 1998 Sep; 273(39):25443-9. PubMed ID: 9738013
[TBL] [Abstract][Full Text] [Related]
4. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
[TBL] [Abstract][Full Text] [Related]
5. Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.
Montano MM; Chaplin LJ; Deng H; Mesia-Vela S; Gaikwad N; Zahid M; Rogan E
Oncogene; 2007 May; 26(24):3587-90. PubMed ID: 17160017
[TBL] [Abstract][Full Text] [Related]
6. Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damage.
Bianco NR; Chaplin LJ; Montano MM
Biochem J; 2005 Jan; 385(Pt 1):279-87. PubMed ID: 15456407
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation by the estrogen receptor of antioxidative stress enzymes and its functional implications.
Montano MM; Deng H; Liu M; Sun X; Singal R
Oncogene; 2004 Apr; 23(14):2442-53. PubMed ID: 14676828
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
9. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
10. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens.
Montano MM; Katzenellenbogen BS
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2581-6. PubMed ID: 9122238
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a novel factor that regulates quinone reductase gene transcriptional activity.
Montano MM; Wittmann BM; Bianco NR
J Biol Chem; 2000 Nov; 275(44):34306-13. PubMed ID: 10908561
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.
Yao Y; Brodie AM; Davidson NE; Kensler TW; Zhou Q
Breast Cancer Res Treat; 2010 Nov; 124(2):585-91. PubMed ID: 20623181
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavones increase quinone reductase in hepa-1c1c7 cells via estrogen receptor beta and nuclear factor erythroid 2-related factor 2 binding to the antioxidant response element.
Froyen EB; Steinberg FM
J Nutr Biochem; 2011 Sep; 22(9):843-8. PubMed ID: 21167702
[TBL] [Abstract][Full Text] [Related]
14. Induction of quinone reductase by tamoxifen or DPN protects against mammary tumorigenesis.
Krishnamurthy N; Hu Y; Siedlak S; Doughman YQ; Watanabe M; Montano MM
FASEB J; 2012 Oct; 26(10):3993-4002. PubMed ID: 22700872
[TBL] [Abstract][Full Text] [Related]
15. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
Lin PH; Lin CH; Huang CC; Chuang MC; Lin P
Toxicol Lett; 2007 Aug; 172(3):146-58. PubMed ID: 17669606
[TBL] [Abstract][Full Text] [Related]
16. Support of a bi-faceted role of estrogen receptor β (ERβ) in ERα-positive breast cancer cells.
Jonsson P; Katchy A; Williams C
Endocr Relat Cancer; 2014 Apr; 21(2):143-60. PubMed ID: 24192230
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H:quinone oxidoreductase-1 gene expression.
Bloom DA; Jaiswal AK
J Biol Chem; 2003 Nov; 278(45):44675-82. PubMed ID: 12947090
[TBL] [Abstract][Full Text] [Related]
18. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
Tonetti DA; Rubenstein R; DeLeon M; Zhao H; Pappas SG; Bentrem DJ; Chen B; Constantinou A; Craig Jordan V
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):47-55. PubMed ID: 14630090
[TBL] [Abstract][Full Text] [Related]
19. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
20. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants.
Dhakshinamoorthy S; Jain AK; Bloom DA; Jaiswal AK
J Biol Chem; 2005 Apr; 280(17):16891-900. PubMed ID: 15734732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
